Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1

被引:196
|
作者
Platt, Emily J. [2 ]
Bilska, Miroslawa
Kozak, Susan L. [2 ]
Kabat, David [2 ]
Montefiori, David C. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA
[2] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
关键词
AMINO-ACID TRANSPORTER; C INFECTION; RETROVIRUSES; EXPRESSION; RECEPTOR; HIV-1; IDENTIFICATION; INTERFERENCE; EPITOPE; FUSION;
D O I
10.1128/JVI.00709-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The TZM-bl cell line that is commonly used to assess neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) was recently reported to be contaminated with an ecotropic murine leukemia virus (MLV) (Y. Takeuchi, M. O. McClure, and M. Pizzato, J. Virol. 82: 12585-12588, 2008), raising questions about the validity of results obtained with this cell line. Here we confirm this observation and show that HIV-1 neutralization assays performed with a variety of serologic reagents in a similar cell line that does not harbor MLV yield results that are equivalent to those obtained in TZM-bl cells. We conclude that MLV contamination has no measurable effect on HIV-1 neutralization when TZM-bl cells are used as targets for infection.
引用
收藏
页码:8289 / 8292
页数:4
相关论文
共 50 条
  • [31] Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
    Dhillon, Amandeep K.
    Donners, Helen
    Pantophlet, Ralph
    Johnson, Welkin E.
    Decker, Julie M.
    Shaw, George M.
    Lee, Fang-Hua
    Richman, Douglas D.
    Doms, Robert W.
    Vanham, Guido
    Burton, Dennis R.
    JOURNAL OF VIROLOGY, 2007, 81 (12) : 6548 - 6562
  • [32] Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines
    Mascola, JR
    D'Souza, P
    Gilbert, P
    Hahn, BH
    Haigwood, NL
    Morris, L
    Petropoulos, CJ
    Polonis, VR
    Sarzotti, M
    Montefiori, DC
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10103 - 10107
  • [33] Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1
    Lathey, JL
    Pratt, RD
    Spector, SA
    JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01): : 231 - 232
  • [34] The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions - Reply
    Lennox, JL
    Villanueva, JM
    Bush, TJ
    Ellerbrock, TV
    Hart, CE
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (05): : 728 - 729
  • [35] Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody
    Zhang, MY
    Xiao, XD
    Sidorov, IA
    Choudhry, V
    Cham, F
    Zhang, PF
    Bouma, P
    Zwick, M
    Choudhary, A
    Montefiori, DC
    Broder, CC
    Burton, DR
    Quinnan, GV
    Dimitrov, DS
    JOURNAL OF VIROLOGY, 2004, 78 (17) : 9233 - 9242
  • [36] Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection
    Wang, Feifei
    Gelais, Corine St.
    de Silva, Suresh
    Zhang, Hong
    Geng, Yu
    Shepard, Caitlin
    Kim, Baek
    Yount, Jacob S.
    Wu, Li
    VIROLOGY, 2016, 487 : 273 - 284
  • [37] Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
    Njai, H. F.
    Tomusange, K.
    Sokolik-Wolak, B.
    Montefiori, D.
    Balla, S.
    Vanham, G.
    Levin, J.
    Maher, D.
    Kamali, A.
    Grosskurth, H.
    Pala, P.
    Kaleebu, P.
    RETROVIROLOGY, 2009, 6
  • [38] Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
    Pilgrim, AK
    Pantaleo, G
    Cohen, OJ
    Fink, LM
    Zhou, JY
    Zhou, JT
    Bolognesi, DP
    Fauci, AS
    Montefiori, DC
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04): : 924 - 932
  • [39] Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors
    Montefiori, DC
    Pantaleo, G
    Fink, LM
    Zhou, JT
    Zhou, JY
    Bilska, M
    Miralles, GD
    Fauci, AS
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01): : 60 - 67
  • [40] Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: Transdominant inhibition by matrix mutations
    Kiernan, RE
    Freed, EO
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 9621 - 9627